# Baicalin

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/baicalin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 8 / 10
**Category:** Compound
**Also Known As:** 5,6,7-trihydroxyflavone-7-O-glucuronide, Baicalein-7-glucuronide, Huang Qin glucuronide, Chinese skullcap flavonoid, Scutellaria flavone, Wogonoside analog

## Overview

Baicalin is a flavone glycoside compound derived from Scutellaria baicalensis (Chinese skullcap) that demonstrates potent [anti-inflammatory](/ingredients/condition/inflammation) activity through inhibition of nuclear factor-kappa B (NF-κB) signaling pathways. Research shows it significantly reduces inflammatory markers like IL-6 and myeloperoxidase in preclinical models of inflammatory bowel disease and arthritis.

## Health Benefits

• [Anti-inflammatory](/ingredients/condition/inflammation) effects: Meta-analysis of 17 animal studies showed significant reduction in inflammatory markers IL-6 (SMD = -10.59) and MPO (SMD = -7.34) in ulcerative colitis models (preliminary evidence only)
• Arthritis management: Reduced paw thickness and inflammatory cytokines in collagen-induced arthritis models via TLR2/MYD88/NF-κB suppression (animal studies only)
• Intestinal barrier protection: Improved disease activity index (MD = -2.75) and histopathology scores (SMD = -3.91) in UC animal models (PMID: 39901089, preliminary evidence)
• [Antioxidant activity](/ingredients/condition/antioxidant): Increased SOD levels and reduced ROS via Bcl-2/Bax modulation in preclinical models (animal/in vitro evidence)
• Anti-cancer synergy: Enhanced apoptosis when combined with chemotherapy in breast cancer models (in vitro evidence only)

## Mechanism of Action

Baicalin exerts its [anti-inflammatory](/ingredients/condition/inflammation) effects primarily through inhibition of the nuclear factor-kappa B (NF-κB) signaling pathway, which regulates inflammatory gene expression. The compound also modulates cyclooxygenase-2 (COX-2) and lipoxygenase enzymes, reducing production of pro-inflammatory prostaglandins and leukotrienes. Additionally, baicalin demonstrates antioxidant activity by scavenging [reactive oxygen species](/ingredients/condition/antioxidant) and upregulating antioxidant enzymes like superoxide dismutase.

## Clinical Summary

Current evidence for baicalin comes primarily from preclinical animal studies, with limited human clinical data available. A meta-analysis of 17 animal studies in ulcerative colitis models showed significant reductions in IL-6 (SMD = -10.59) and myeloperoxidase (SMD = -7.34) [inflammatory](/ingredients/condition/inflammation) markers. In arthritis models, baicalin reduced paw swelling and inflammatory cytokines, though effect sizes and dosages varied across studies. Human clinical trials are needed to establish therapeutic efficacy and optimal dosing protocols.

## Nutritional Profile

Baicalin is a flavonoid glycoside (flavone class) and not a food ingredient with conventional macronutrient or micronutrient content. It is a purified bioactive compound, therefore standard nutritional profiling (calories, protein, fat, carbohydrates) is not applicable in the traditional sense. Key compositional data: Molecular formula C21H18O11, molecular weight 446.36 g/mol. It is the glucuronide conjugate of baicalein, with a glucuronic acid moiety attached at the 7-position of the baicalein backbone. Primary source: Root of Scutellaria baicalensis (Chinese skullcap), where baicalin constitutes approximately 10–15% dry weight of the root, with some extracts standardized to 85–95% baicalin purity in supplement form. Typical commercial extract concentrations range from 200 mg to 500 mg per capsule dose. Bioavailability is notably limited due to poor water solubility (approximately 0.2 mg/mL in water) and extensive first-pass [metabolism](/ingredients/condition/weight-management); oral bioavailability is estimated at less than 2–3% in its intact glycoside form. Intestinal microbiota and gut mucosal β-glucuronidase enzymes hydrolyze baicalin to its aglycone baicalein, which is more readily absorbed. Peak plasma concentration (Cmax) following oral administration in human pharmacokinetic studies is typically low (nanomolar to low micromolar range). No significant vitamin, mineral, fiber, or protein content is present as it is an isolated phytochemical compound, not a whole food.

## Dosage & Preparation

No human dosage data exists for baicalin. Animal studies suggest 60-150 mg/kg for ulcerative colitis models over 10-14 days. Related compound baicalein has been tested at 200-600 mg/day in humans with good tolerability. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Baicalin appears generally well-tolerated in animal studies, though comprehensive human safety data is lacking. The compound may interact with cytochrome P450 enzymes, particularly CYP2C9 and CYP3A4, potentially affecting [metabolism](/ingredients/condition/weight-management) of certain medications including warfarin and some statins. Theoretical concerns exist regarding additive effects with anticoagulant medications due to potential bleeding risk. Safety during pregnancy and lactation has not been established, and use should be avoided in these populations.

## Scientific Research

Clinical evidence for baicalin is limited to preclinical studies, with no human trials identified. A 2024 meta-analysis of 17 animal RCTs (PMID: 39901089) demonstrated significant improvements in ulcerative colitis biomarkers, but emphasized the urgent need for human studies. Human safety data exists only for the related compound baicalein (200-600 mg/day), not baicalin itself.

## Historical & Cultural Context

Baicalin originates from Scutellaria baicalensis roots, used in Traditional Chinese Medicine for over 2,000 years to clear heat, dry dampness, and treat inflammatory conditions like fever, dysentery, and respiratory infections. Historical TCM applications for [anti-inflammatory](/ingredients/condition/inflammation) and detoxifying purposes form the basis for modern research into arthritis and colitis.

## Synergistic Combinations

Baicalein, Curcumin, Quercetin, Green Tea Extract, Boswellia

## Frequently Asked Questions

### What is the typical dosage of baicalin for inflammation?

Human dosing has not been established through clinical trials. Animal studies used doses ranging from 25-200 mg/kg body weight, but these cannot be directly translated to human recommendations without proper clinical research.

### How long does it take for baicalin to show anti-inflammatory effects?

In animal models, baicalin showed measurable reductions in inflammatory markers within 1-2 weeks of treatment. However, the timeline for effects in humans remains unknown due to lack of clinical studies.

### Can baicalin be taken with blood thinners?

Baicalin may interact with anticoagulant medications like warfarin by affecting liver enzymes that metabolize these drugs. Consult a healthcare provider before combining baicalin with any blood-thinning medications.

### Is baicalin the same as baicalein?

No, baicalin is the glycoside form while baicalein is the aglycone (sugar-free) form of the same flavonoid compound. Baicalin is converted to baicalein in the body, and both forms show biological activity.

### What foods contain baicalin naturally?

Baicalin is found primarily in Scutellaria baicalensis (Chinese skullcap) root, which is not a common food but rather a traditional medicinal herb. It's not naturally present in significant amounts in typical dietary sources.

### What does the research show about baicalin's effectiveness for gut health and intestinal barrier function?

Animal studies suggest baicalin may support intestinal barrier integrity through anti-inflammatory mechanisms targeting the TLR2/MYD88/NF-κB pathway, with preliminary evidence in ulcerative colitis models showing significant reductions in inflammatory markers IL-6 and MPO. However, human clinical trials are limited, so current evidence is considered preliminary and more research is needed to establish efficacy in people. The mechanism appears to involve reducing inflammatory cytokines that damage the intestinal lining.

### Who should consider baicalin supplementation, and are there populations that should avoid it?

Individuals interested in natural anti-inflammatory support, particularly those with inflammatory conditions like arthritis or colitis, may consider baicalin based on animal evidence. However, pregnant or nursing women should consult a healthcare provider before use due to limited safety data in these populations. Those with bleeding disorders or taking anticoagulant medications should exercise caution, as baicalin may have mild anticoagulant properties.

### How does baicalin's potency compare to other flavonoids used for inflammation management?

Baicalin is a flavone glycoside with a specific anti-inflammatory mechanism through NF-κB suppression that differs from some other flavonoids, though direct comparative studies in humans are scarce. Animal models show baicalin produces substantial reductions in inflammatory markers, but head-to-head clinical comparisons with other well-studied anti-inflammatory compounds like curcumin or quercetin have not been extensively conducted. Its effectiveness relative to other flavonoids may depend on the specific inflammatory pathway involved.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*